Harmony Biosciences Holdings, Inc.
HRMY
$27.85
-$0.52-1.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -54.55% | 10.35% | 243.16% | 18.85% | 85.95% |
| Total Depreciation and Amortization | 24.53% | 0.00% | -1.40% | -2.55% | -2.56% |
| Total Amortization of Deferred Charges | -7.10% | -8.00% | -7.39% | -7.78% | -8.65% |
| Total Other Non-Cash Items | 433.12% | 229.19% | -49.33% | 19.40% | -65.85% |
| Change in Net Operating Assets | 368.11% | 157.54% | 193.01% | -27.23% | -50.02% |
| Cash from Operations | 66.95% | 54.23% | 86.14% | 9.14% | -1.44% |
| Capital Expenditure | 79.14% | -2,266.67% | 99.37% | -2,460.00% | -379.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -162.60% | -730.75% | 7.42% | 140.28% | -761.45% |
| Cash from Investing | -145.35% | -742.82% | 64.29% | 138.18% | 80.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -33.33% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -18.20% | -70.72% | 265.97% | 3,956.90% | 1,325.99% |
| Repurchase of Common Stock | 70.24% | -- | -284.01% | -- | 95.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -10.00% | -154.98% | 22.05% | 90.31% | 94.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 60.74% | 44.07% | 463.74% | 68.83% | 607.89% |